BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16601750)

  • 1. The complexity of p53 stabilization and activation.
    Lavin MF; Gueven N
    Cell Death Differ; 2006 Jun; 13(6):941-50. PubMed ID: 16601750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation.
    Kawano T; Akiyama M; Agawa-Ohta M; Mikami-Terao Y; Iwase S; Yanagisawa T; Ida H; Agata N; Yamada H
    Int J Oncol; 2010 Oct; 37(4):787-95. PubMed ID: 20811699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of MDM2 Stability After DNA Damage.
    Li J; Kurokawa M
    J Cell Physiol; 2015 Oct; 230(10):2318-27. PubMed ID: 25808808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
    Lee JH; Kim HS; Lee SJ; Kim KT
    J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.
    Rinaldo C; Prodosmo A; Mancini F; Iacovelli S; Sacchi A; Moretti F; Soddu S
    Mol Cell; 2007 Mar; 25(5):739-50. PubMed ID: 17349959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation.
    Stommel JM; Wahl GM
    Cell Cycle; 2005 Mar; 4(3):411-7. PubMed ID: 15684615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy.
    Birks EJ; Latif N; Enesa K; Folkvang T; Luong le A; Sarathchandra P; Khan M; Ovaa H; Terracciano CM; Barton PJ; Yacoub MH; Evans PC
    Cardiovasc Res; 2008 Aug; 79(3):472-80. PubMed ID: 18375498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
    Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-box protein FBXO31 directs degradation of MDM2 to facilitate p53-mediated growth arrest following genotoxic stress.
    Malonia SK; Dutta P; Santra MK; Green MR
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8632-7. PubMed ID: 26124108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
    Vaziri H; West MD; Allsopp RC; Davison TS; Wu YS; Arrowsmith CH; Poirier GG; Benchimol S
    EMBO J; 1997 Oct; 16(19):6018-33. PubMed ID: 9312059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours?
    Meek DW; Hupp TR
    Semin Cancer Biol; 2010 Feb; 20(1):19-28. PubMed ID: 19897041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2.
    Lee SJ; Lim CJ; Min JK; Lee JK; Kim YM; Lee JY; Won MH; Kwon YG
    Cell Death Differ; 2007 Jun; 14(6):1106-16. PubMed ID: 17318220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ubiquitin modification in the regulation of p53.
    Hock AK; Vousden KH
    Biochim Biophys Acta; 2014 Jan; 1843(1):137-49. PubMed ID: 23742843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP-1 modifies the effectiveness of p53-mediated DNA damage response.
    Valenzuela MT; Guerrero R; Núñez MI; Ruiz De Almodóvar JM; Sarker M; de Murcia G; Oliver FJ
    Oncogene; 2002 Feb; 21(7):1108-16. PubMed ID: 11850828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of p53 in response to DNA damage.
    Lakin ND; Jackson SP
    Oncogene; 1999 Dec; 18(53):7644-55. PubMed ID: 10618704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells.
    Brew CT; Aronchik I; Hsu JC; Sheen JH; Dickson RB; Bjeldanes LF; Firestone GL
    Int J Cancer; 2006 Feb; 118(4):857-68. PubMed ID: 16152627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxic and non-genotoxic pathways of p53 induction.
    Pluquet O; Hainaut P
    Cancer Lett; 2001 Dec; 174(1):1-15. PubMed ID: 11675147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.
    Yang Y; Ludwig RL; Jensen JP; Pierre SA; Medaglia MV; Davydov IV; Safiran YJ; Oberoi P; Kenten JH; Phillips AC; Weissman AM; Vousden KH
    Cancer Cell; 2005 Jun; 7(6):547-59. PubMed ID: 15950904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.